The Pennant Group (NASDAQ:PNTG – Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 1.030-1.110 for the period, compared to the consensus earnings per share estimate of 1.080. The company issued revenue guidance of $800.0 million-$865.0 million, compared to the consensus revenue estimate of $816.2 million.
Analyst Upgrades and Downgrades
A number of research firms recently commented on PNTG. Truist Financial lowered their price target on shares of The Pennant Group from $38.00 to $32.00 and set a “hold” rating on the stock in a report on Monday, January 6th. Wells Fargo & Company began coverage on The Pennant Group in a research note on Thursday, December 19th. They issued an “equal weight” rating and a $33.00 target price on the stock. Finally, Oppenheimer increased their price target on The Pennant Group from $34.00 to $37.00 and gave the stock an “outperform” rating in a research note on Friday, November 8th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $36.00.
View Our Latest Report on PNTG
The Pennant Group Price Performance
About The Pennant Group
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
Read More
- Five stocks we like better than The Pennant Group
- Investing In Preferred Stock vs. Common Stock
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- What Are Dividend Challengers?
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- How to Use the MarketBeat Excel Dividend Calculator
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.